C2i Genomics

Acquired

C2i Genomics is an artificial intelligence company in New York, United States, founded in 2019. It has raised $112.0M across 2 rounds, most recently a $100.0M Series B in April 2021.

Cancer intelligence through AI and whole-genome sequencing

Headquarters
New York, New York
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$112.0M
Last Round
$100.0M Series BApr 2021
Rounds
2
Acquired by
Veracyte$70.0M

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.

About

C2i Genomics developed a cloud-based cancer intelligence platform that applies artificial intelligence and whole-genome sequencing to liquid biopsy samples to detect minimal residual disease (MRD) in cancer patients. The company's C2-Intelligence Platform analyzes blood samples to provide highly precise cancer detection and treatment monitoring, enabling pharmaceutical and diagnostic organizations to track cancer recurrence and optimize treatment decisions. C2i partnered with AstraZeneca and Premier Inc. before being acquired by Veracyte in February 2024.

Summary

It lists 11–50 employees. It has raised $112.0M in total across 2 rounds, most recently a $100.0M Series B round in Apr 2021. Investors include Casdin Capital, NFX and The Mark Foundation for Cancer Research.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Series BSeries BApr 2021
$100.0M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

C2i Genomics on Indexed.vc
<a href="https://indexed.vc/companies/c2i-genomics"><img src="https://indexed.vc/api/badge/company/c2i-genomics" alt="C2i Genomics on Indexed.vc" width="260" height="76" /></a>